DNA GTx’s EGFR Test is designed to detect 8 key mutations (55 known variants) within exons 18–21 of the EGFR gene, which are commonly associated with non-small cell lung cancer (NSCLC). This focused test delivers rapid and accurate results, enabling oncologists to identify patients eligible for EGFR-targeted therapies and make informed decisions for personalized lung cancer care.
Yes. A doctor must order this test to ensure the results are properly interpreted and used to guide treatment.
Let’s Decode the Future of Health — Together
Get in touch today — let’s start a conversation that could change lives
*All information is handled with strict confidentiality.
Find Answers Today
Early detection saves lives
*All information is handled with strict confidentiality.